Clinical Research
Advancing Heart Valve Research
At the Marcus Heart Valve Center, we actively engage in heart valve research. This allows us to offer customized diagnostic and therapeutic options for patients that may otherwise not be accessible.
Our leading-edge cardiac research program is focused on evaluating new treatments and technologies, particularly percutaneous (non-surgical/minimally invasive) treatment options for all heart valves.
Currently Enrolling Research Trials
Aortic
Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects Indicated for TAVR.
ALIGN AR: A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients with Symptomatic, Severe Aortic Regurgitation (AR).
Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves.
Mitral
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation – APOLLO Trial.
Cephea Early Feasibility Study
To evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral regurgitation > Grade III in whom transcatheter therapy is deemed more appropriate than open heart surgery.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP IID/IIF): A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCA.
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System.
Percutaneous or Surgical Repair in Mitral Prolapse for > 65 Year-olds.
Percutaneous MitraClip™ Device or Surgical Mitral Valve Repair in Patients with Primary Mitral Regurgitation who are Candidates for Surgery.
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation.
Prospective, single-arm, early feasibility study (EFS) for the treatment of subjects with moderate-severe or severe symptomatic mitral valve regurgitation using the Innovalve Transseptal Mitral Valve Replacement (TMVR) System.
Tricuspid
CA prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation.
Early Feasibility Study of the Duo Transcatheter Tricuspid Coaptation Valve System in Patients with Tricuspid Regurgitation.
Early Feasibility Study of the Trisol System.
For full details visit the Clinical Trials Database.